ABIOMED, Inc.
189.5100
0.42%
189.5100
0.42%
103.5300 198.2900
52 weeks
52 weeks

Mkt Cap 8.35B

Shares Out 44.06M

new Chat
Send me real-time posts from this site at my email

ABIOMED, Inc.

ABIOMED, Inc. reports financial results for the quarter ended June 30, 2017.We analyze the earnings along side the following peers of ABIOMED, Inc. - Boston Scientific Corporation and AtriCure, Inc. (BSX-US and ATRC-US) that have also reported for this period.

  • Summary numbers: Revenues of USD 132.47 million, Net Earnings of USD 37.37 million.
  • Gross margins narrowed from 85.37% to 83.50% compared to the same period last year, operating (EBITDA) margins now 27.03% from 22.15%.
  • Year-on-year change in operating cash flow of 37.58% is about the same as the change in earnings, likely no significant movement in accruals or reserves.
  • Earnings growth from operating margin improvements as well as one-time items.

The table below shows the preliminary results and recent trends for key metrics such as revenues and net income growth:

2017-06-302017-03-312016-12-312016-09-302016-06-30
Revenues (mil)132.5124.7114.7103103
Revenue Growth (%YOY)28.632.733.734.840.3
Earnings (mil)37.414.915.48.912.9
Earnings Growth (%YOY)189.535.546.214.745.7
Net Margin (%)28.211.913.58.612.5
EPS0.820.330.340.20.29
Return on Equity (%)7.33.43.82.33.5
Return on Assets (%)24.911.312.77.912.1

Click here to view

Spreadsheet

Spreadsheet

ABMD-US's change in revenue this period compared to the same period last year of 28.62% is almost the same as its change in...


More
Cancel
Followers
1